期刊文献+

冠心病并糖尿病患者血栓形成前状态分子标志物变化及机制研究 被引量:4

Change and significance of molecular markers of prethrombotic state in coronary artery disease patients with diabetes mellitus
原文传递
导出
摘要 目的 :观察冠心病 (CHD)并 2型糖尿病 (NIDDM)患者血栓形成前状态 (PTS)分子标志物的变化 ,并探讨其机制。方法 :对 2 0例稳定型心绞痛 (SAP)、2 0例不稳定型心绞痛 (UAP)、2 8例UAP并NIDDM患者以及2 0例正常人体内PTS分子标志物、血管内皮功能以及脂质过氧化物水平进行系列检测。结果 :CHD患者尤其是并NIDDM患者体内存在明显的PTS分子标志物变化 ,并且以并糖尿病 (DM)微血管病变者或伴有心脏事件发生者更为明显 ,与此同时 ,这些患者的内皮功能障碍及脂质过氧化损伤明显。Logistic回归分析表明心脏事件发生与血管性假血友病因子、抗凝血酶Ⅲ、血浆血小板颗粒膜糖蛋白 14 0、血浆纤维蛋白原变化尤其密切 ,并且后者变化与内皮功能失调及脂质过氧化损伤密切相关。结论 :CHD尤其是并NIDDM患者存在明显的PTS分子标志物变化 ,这种变化在DM微血管病变者尤其明显 ,并与心脏事件发生密切相关。其产生机制可能与血管内皮功能障碍。 Objective:To observe the changes of molecular markers of prethrombotic state (PTS) in coronary artery disease (CHD)patients with non insulin dependent diabetes mellitus (NIDDM). Methods:Molecular markers of PTS, vascular endothelial function and lipid peroxidate were measured in 20 patients with stable angina pectoris, 20 patients with unstable angina pectoris(UAP), 28 UAP pateints with NIDDM and 20 normal cases. Results:There were significant changes of molecular markers of PTS in CHD patients, especially in those with NIDDM, which were more pronounced in those with diabetic microvascular disease and those with cardiac events. Meanwhile,there were significant endothelial disfunction and injury of lipid peroxide in those patients. Logistic regression analysis showed that there were close relationships between cardiac events and vWF, ATⅢ, GMP 140, Fbg, which were closely related with endothelial disfunction and injury of lipid peroxide. Conclusion:There were significant changes of molecular markers of PTS in CHD patients especially in those with NIDDM, which were even more pronounced in those with diabetic microvascular disease and were closely related with cardiac events. The mechanisms may be related with endothelial disfunction and injury of lipid peroxide.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2003年第8期468-471,共4页 Journal of Clinical Cardiology
基金 海南省自然科学基金资助课题 (No .39812 )
关键词 冠状动脉疾病 糖尿病 血栓形成 Coronary artery disease Diabetes mellitus Thrombosis
  • 相关文献

参考文献6

  • 1Superke H R, Hecht H S. Metabolic disorders contrbbute to subclinical coronary atherosclerosis in patients with coronary calcification. Am J Cardiol, 2001, 88:260--264. 被引量:1
  • 2Maly J, Fecka M, Pidrman V, et al. Antithroin Ⅲ in various conditions in internal medicine. Vinitr Lek,1997,43:645--648. 被引量:1
  • 3Angeja B G, Bundle A C, Guiwitz J H, et al. Death or norfatal stroke in patients with acute myocardial infarction treatment with tissue plasminogen activator. Am J Cardiol, 2001,87 : 627 -- 629. 被引量:1
  • 4Heitzer T, Schliinzig T, Krohn K, et al. Endothelial disfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation, 2002, 104:2673--2678. 被引量:1
  • 5Sabatine D, Brunwald E. Will diabetes save the patelet blockers? Circulation, 2001,104: 2759--2761. 被引量:1
  • 6Rickel C, Rupprecht H J, Blankenbery S, et al. Relation of inflammation (c-reaction protein, fibinogen, ven Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol,2002,89:901-908. 被引量:1

同被引文献21

  • 1金元玖,李正信,苗秀兰,张颖.不同临床类型冠心病患者抗凝血酶III和纤溶系统的变化[J].中国医师杂志,2005,7(3):416-417. 被引量:10
  • 2LOWE G D,SWEETNAM P M,YARNELL J W G, et al. C reactive protein,fibrin D-dimer,and risk of is chemic heart disease[J].Arterioscler Thromb Vasc Biol, 2004,24 : 1957-1962. 被引量:1
  • 3KOHLER H P. Plasminogen activator inhibitor type 1 and coronary artery disease[J]. N Engl J Med, 2000,342 : 1792-1795. 被引量:1
  • 4Sun R J, Muller S, Wang X, et al. Regulation of von Willebrand factor of human endothelial cells exposed to laminar flows: an in vitro study. Clin Hemorheol Microcirc, 2000, 23:1-11. 被引量:1
  • 5池田康夫.冠脉血栓形成的分子机制[N].日本《医学论坛报》,2001,34:23-26. 被引量:1
  • 6Mannucci P M. Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proc Natl Acad Sci USA ,1995,92: 2428. 被引量:1
  • 7Newsholme S J, Thudium D T, Gossett K A, et al. Evaluation of plasma von Willebrand factor as a biomarker for acute arterial damage in rats. Toxicol Pathol, 2000, 28: 688-693. 被引量:1
  • 8Montalescot G, Collet J P, Lison L, et al. Effects of various anticoagulant treatment on von Willebrand factor release in unstable angina. J Am Coll Cadiol ,2000, 36: 110-114. 被引量:1
  • 9Mossard J M, Wiesel M L, Cazenave J P, et al. Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis. Arch Mal Coeur Vaiss, 1989,82: 1813-1818. 被引量:1
  • 10Ikeda Y, Handa M, Murata M, et al. A new approach to antiplatlet therapy: inhibitor of gpib/Ⅴ/Ⅸ-vwf interaction. Haemostasis ,2000,30: 44-52. 被引量:1

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部